Bausch + Lomb study finds enVista Aspire IOLs deliver strong distance, intermediate vision in real-world use

• Bausch + Lomb announced publication of a real-world study on enVista Aspire and enVista Aspire toric intraocular lenses.
• Results were already published in Ophthalmology and Therapy.
• Study found the lenses delivered strong distance vision with useful intermediate vision in routine cataract surgery settings.
• Safety profile was favorable, with no serious adverse events reported in the reviewed cases.
• Findings support broader positioning of the Aspire platform for patients seeking more functional vision without moving to premium multifocals.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch + Lomb Corp. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260902448386) on September 02, 2026, and is solely responsible for the information contained therein.